Sidney Blumenthal, a former senior adviser to President Bill Clinton, examines Conley’s approval in an article for Just Security and poses a series of questions for the White House doctor.
Following Trump’s hydroxychloroquine announcement, Conley said that he had discussed the matter with the president. Conley said in a press release: “After numerous discussions he and I had regarding the evidence for and against the use of hydroxychloroquine, we concluded the potential benefit from treatment outweighed the relative risks.” Continue reading.